{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:33Z","timestamp":1786933473543,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases\u2013National Science and Technology Major Project","award":["2025ZD0545600"],"award-info":[{"award-number":["2025ZD0545600"]}]},{"name":"Zhongda Hospital, Southeast University; Jiangsu Province High-Level Hospital Programs","award":["2023GSPKY11, GSP-LCYJFH01"],"award-info":[{"award-number":["2023GSPKY11, GSP-LCYJFH01"]}]},{"name":"National Clinical Key Discipline Construction Funds","award":["CZXM-ZK-40"],"award-info":[{"award-number":["CZXM-ZK-40"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372126, 82072078"],"award-info":[{"award-number":["82372126, 82072078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Major Science and Technology Special Project","award":["202305039"],"award-info":[{"award-number":["202305039"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-Zai2022\/MS-0126"],"award-info":[{"award-number":["Y-Zai2022\/MS-0126"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04675-w","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:03:53Z","timestamp":1781150633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico design of CLDN4-directed peptide-loaded nanobubbles for ultrasound-assisted delivery, photothermal therapy, immune activation, and multimodal imaging in ovarian cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"5","key":"4675_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21(5):389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"4675_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","volume":"334","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian Cancer: A Review. JAMA. 2025;334(14):1278\u201391.","journal-title":"JAMA"},{"key":"4675_CR3","doi-asserted-by":"crossref","unstructured":"Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE, Okamoto A, Moore K, Kridelka F, McNeish I, Reuss A, Votan B, du Bois A, Mahner S, Ray-Coquard I, Kohn EC, Berek JS, Tan DSP, Colombo N, Zang R, Concin N, O\u2019Donnell D, Rauh-Hain A, Herrington CS, Marth C, Poveda A, Fujiwara K, Stuart GC. E.;, Oza AM, Bookman MA. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet. Oncology 2022, 23 (8), e374-e384.","DOI":"10.1016\/S1470-2045(22)00139-5"},{"issue":"16","key":"4675_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1200\/JCO.19.00500","volume":"37","author":"S Bouberhan","year":"2019","unstructured":"Bouberhan S, Shea M, Cannistra SA. Advanced Epithelial Ovarian Cancer: Do More Options Mean Greater Benefits? J Clin oncology: official J Am Soc Clin Oncol. 2019;37(16):1359\u201364.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"10","key":"4675_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","volume":"42","author":"E Bayraktar","year":"2024","unstructured":"Bayraktar E, Chen S, Corvigno S, Liu J, Sood AK. Ovarian cancer metastasis: Looking beyond the surface. Cancer Cell. 2024;42(10):1631\u20136.","journal-title":"Cancer Cell"},{"issue":"8","key":"4675_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","volume":"33","author":"NS Horowitz","year":"2015","unstructured":"Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin oncology: official J Am Soc Clin Oncol. 2015;33(8):937\u201343.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"10","key":"4675_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.2472","volume":"17","author":"GM van Dam","year":"2011","unstructured":"van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-\u03b1 targeting: first in-human results. Nat Med. 2011;17(10):1315\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"4675_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.122.063372","volume":"148","author":"DG Johns","year":"2023","unstructured":"Johns DG, Campeau LC, Banka P, Bautmans A, Bueters T, Bianchi E, Branca D, Bulger PG, Crevecoeur I, Ding FX, Garbaccio RM, Guetschow ED, Guo Y, Ha SN, Johnston JM, Josien H, Kauh EA, Koeplinger KA, Kuethe JT, Lai E, Lanning CL, Lee AYH, Li L, Nair AG, O\u2019Neill EA, Stoch SA, Thaisrivongs DA, Tucker TJ, Vachal P, van Dyck K, Vanhoutte FP, Volckaert B, Wolford DG, Xu A, Zhao T, Zhou D, Zhou S, Zhu X, Zokian HJ, Walji AM, Wood HB. Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor. Circulation. 2023;148(2):144\u201358.","journal-title":"Circulation"},{"issue":"10","key":"4675_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.tcb.2020.08.004","volume":"30","author":"T Otani","year":"2020","unstructured":"Otani T, Furuse M. Tight Junction Structure and Function Revisited. Trends Cell Biol. 2020;30(10):805\u201317.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"4675_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/35067088","volume":"2","author":"S Tsukita","year":"2001","unstructured":"Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2(4):285\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10389","key":"4675_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","volume":"401","author":"K Shitara","year":"2023","unstructured":"Shitara K, Lordick F, Bang YJ, Enzinger P, Ilson D, Shah MA, Van Cutsem E, Xu RH, Aprile G, Xu J, Chao J, Pazo-Cid R, Kang YK, Yang J, Moran D, Bhattacharya P, Arozullah A, Park JW, Oh M, Ajani JA. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet (London England). 2023;401(10389):1655\u201368.","journal-title":"Lancet (London England)"},{"issue":"8","key":"4675_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","volume":"29","author":"MA Shah","year":"2023","unstructured":"Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, Ilson D, Lordick F, Van Cutsem E, Gallego Plazas J, Huang J, Shen L, Oh SC, Sunpaweravong P, Soo Hoo HF, Turk HM, Oh M, Park JW, Moran D, Bhattacharya P, Arozullah A, Xu RH. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat Med. 2023;29(8):2133\u201341.","journal-title":"Nat Med"},{"issue":"5","key":"4675_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","volume":"21","author":"I Nakayama","year":"2024","unstructured":"Nakayama I, Qi C, Chen Y, Nakamura Y, Shen L, Shitara K. Claudin 18.2 as a novel therapeutic target. Nat Rev Clin Oncol. 2024;21(5):354\u201369.","journal-title":"Nat Rev Clin Oncol"},{"key":"4675_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","volume":"171","author":"J Brunner","year":"2021","unstructured":"Brunner J, Ragupathy S, Borchard G. Target specific tight junction modulators. Adv Drug Deliv Rev. 2021;171:266\u201388.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"4675_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/nn700370b","volume":"2","author":"R Kumar","year":"2008","unstructured":"Kumar R, Roy I, Ohulchanskyy TY, Goswami LN, Bonoiu AC, Bergey EJ, Tramposch KM, Maitra A, Prasad PN. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano. 2008;2(3):449\u201356.","journal-title":"ACS Nano"},{"key":"4675_CR16","doi-asserted-by":"crossref","unstructured":"Fujiwara-Tani R, Mori S, Ogata R, Sasaki R, Ikemoto A, Kishi S, Kondoh M, Kuniyasu H. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy. Int J Mol Sci 2023, 24(6):5494.","DOI":"10.3390\/ijms24065494"},{"issue":"1","key":"4675_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43046-022-00125-4","volume":"34","author":"L Uthayanan","year":"2022","unstructured":"Uthayanan L, El-Bahrawy M. Potential roles of claudin-3 and claudin-4 in ovarian cancer management. J Egypt Natl Cancer Inst. 2022;34(1):24.","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"7","key":"4675_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gutjnl-2012-302577","volume":"62","author":"A Neesse","year":"2013","unstructured":"Neesse A, Hahnenkamp A, Griesmann H, Buchholz M, Hahn SA, Maghnouj A, Fendrich V, Ring J, Sipos B, Tuveson DA, Bremer C, Gress TM, Michl P. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut. 2013;62(7):1034\u201343.","journal-title":"Gut"},{"issue":"3","key":"4675_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/gast.2001.27124","volume":"121","author":"P Michl","year":"2001","unstructured":"Michl P, Buchholz M, Rolke M, Kunsch S, L\u00f6hr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology. 2001;121(3):678\u201384.","journal-title":"Gastroenterology"},{"key":"4675_CR20","doi-asserted-by":"publisher","first-page":"33632","DOI":"10.1038\/srep33632","volume":"6","author":"T Shinoda","year":"2016","unstructured":"Shinoda T, Shinya N, Ito K, Ohsawa N, Terada T, Hirata K, Kawano Y, Yamamoto M, Kimura-Someya T, Yokoyama S, Shirouzu M. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin. Sci Rep. 2016;6:33632.","journal-title":"Sci Rep"},{"issue":"1","key":"4675_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C. Therapeutic peptides: current applications and future directions. Signal Transduct Target therapy. 2022;7(1):48.","journal-title":"Signal Transduct Target therapy"},{"issue":"15","key":"4675_CR22","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.cell.2022.05.029","volume":"185","author":"PJ Carter","year":"2022","unstructured":"Carter PJ, Rajpal A. Designing antibodies as therapeutics. Cell. 2022;185(15):2789\u2013805.","journal-title":"Cell"},{"key":"4675_CR23","doi-asserted-by":"crossref","unstructured":"Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, Meijer D, Terlouw BR, Biermann F, Blin K, Durairaj J, Gorostiola Gonz\u00e1lez M, Helfrich EJN, Huber F, Leopold-Messer S, Rajan K, de Rond T, van Santen JA, Sorokina M, Balunas MJ, Beniddir MA, van Bergeijk DA, Carroll LM, Clark CM, Clevert DA, Dejong CA, Du C, Ferrinho S, Grisoni F, Hofstetter A, Jespers W, Kalinina OV, Kautsar SA, Kim H, Leao TF, Masschelein J, Rees ER, Reher R, Reker D, Schwaller P, Segler M, Skinnider MA, Walker AS, Willighagen EL, Zdrazil B, Ziemert N, Goss RJM, Guyomard P, Volkamer A, Gerwick WH, Kim HU, M\u00fcller R, van Wezel GP, van Westen RG, Robinson SL, Medema. M. H., Artificial intelligence for natural product drug discovery. Nature reviews. Drug discovery 2023, 22 (11), 895\u2013916.","DOI":"10.1038\/s41573-023-00774-7"},{"issue":"11","key":"4675_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17(11):657\u201374.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4675_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","volume":"9","author":"B Wang","year":"2024","unstructured":"Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y, Wang K, Xu J, Cheng Y, Gao X. Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct Target therapy. 2024;9(1):200.","journal-title":"Signal Transduct Target therapy"},{"issue":"4","key":"4675_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0003-3928(02)00109-9","volume":"51","author":"M Schneider","year":"2002","unstructured":"Schneider M. [Contrast media in ultrasonography: from synthesis to clinical use. The Sonovue example]. Ann Cardiol Angeiol. 2002;51(4):218\u201320.","journal-title":"Ann Cardiol Angeiol"},{"issue":"26","key":"4675_CR27","first-page":"29085","volume":"12","author":"DVB Batchelor","year":"2020","unstructured":"Batchelor DVB, Abou-Saleh RH, Coletta PL, McLaughlan JR, Peyman SA, Evans SD. Nested Nanobubbles for Ultrasound-Triggered Drug Release. ACS Appl Mater Interfaces. 2020;12(26):29085\u201393.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"28","key":"4675_CR28","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","volume":"18","author":"BN Yalamandala","year":"2024","unstructured":"Yalamandala BN, Chen YJ, Lin YH, Huynh TMH, Chiang WH, Chou TC, et al. A self-cascade penetrating brain tumor immunotherapy mediated by near-infrared II cell membrane-disrupting nanoflakes via detained dendritic cells. ACS nano. 2024;18(28):18712\u201328.","journal-title":"ACS nano"},{"issue":"5","key":"4675_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41416-022-02076-y","volume":"128","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang Y, Liu Y, Wang W, Gao S, Yuan W, et al. Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect. British journal of cancer. 2023;128(5):715\u201325.","journal-title":"British journal of cancer"},{"key":"4675_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937344","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y. Ultrasound-targeted microbubble destruction: modulation in the tumor microenvironment and application in tumor immunotherapy. Frontiers in immunology. 2022;13:937344.","journal-title":"Frontiers in immunology"},{"issue":"27","key":"4675_CR31","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH. Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation. ACS nano. 2025;19(27):25134\u201353.","journal-title":"ACS nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04675-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:52:53Z","timestamp":1786931573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04675-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4675"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04675-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The collection and use of human ovarian cancer specimens were approved by the Ethics Review Committee of Southeast University Zhongda Hospital (ERC-SEU-ZDH-2023-0147), and written informed consent was obtained from all participants in accordance with the Declaration of Helsinki. Animal studies were approved by the Animal Care Committee of Southeast University (20240402301).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s identifiable data, images, or videos.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"764"}}